A sticky situation: Aberrant protein-protein interactions in Parkinson's disease.

Brown J, Horrocks MH.

Semin Cell Dev Biol. 2020 Mar;99:65-77. doi: 10.1016/j.semcdb.2018.05.006. Epub 2018 May 10. Review.

Balance and mobility in patients with newly diagnosed Parkinson's disease - a five-year follow-up of a cohort in northern Sweden.

Johansson C, Lindström B, Forsgren L, Johansson GM.

Disabil Rehabil. 2020 Mar;42(6):770-778. doi: 10.1080/09638288.2018.1509240. Epub 2018 Nov 19.

Bioluminescence-driven optogenetic activation of transplanted neural precursor cells improves motor deficits in a Parkinson's disease mouse model.

Zenchak JR, Palmateer B, Dorka N, Brown TM, Wagner LM, Medendorp WE, Petersen ED, Prakash M, Hochgeschwender U.

J Neurosci Res. 2020 Mar;98(3):458-468. doi: 10.1002/jnr.24237. Epub 2018 Mar 25.

Executive function but not episodic memory decline associated with visual hallucinations in Parkinson's disease.

Creese B, Albertyn CP, Dworkin S, Thomas RS, Wan YM, Ballard C.

J Neuropsychol. 2020 Mar;14(1):85-97. doi: 10.1111/jnp.12169. Epub 2018 Jul 23.

A Survey of Application of Complementary and Alternative Medicine in Chinese Patients with Parkinson's Disease: A Pilot Study.

Pan XW, Zhang XG, Chen XC, Lu Q, Hu YS, Han LY, Zheng JL, Jin J, Zheng GQ.

Chin J Integr Med. 2020 Mar;26(3):168-173. doi: 10.1007/s11655-018-2560-y. Epub 2018 Jun 18.

Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.

Dodiya HB, Forsyth CB, Voigt RM, Engen PA, Patel J, Shaikh M, Green SJ, Naqib A, Roy A, Kordower JH, Pahan K, Shannon KM, Keshavarzian A.

Neurobiol Dis. 2020 Feb;135:104352. doi: 10.1016/j.nbd.2018.12.012. Epub 2018 Dec 21. Review.

Neuropsychiatric complications and neuroimaging characteristics after deep brain stimulation surgery for Parkinson's disease.

Radziunas A, Deltuva VP, Tamasauskas A, Gleizniene R, Pranckeviciene A, Surkiene D, Bunevicius A.

Brain Imaging Behav. 2020 Feb;14(1):62-71. doi: 10.1007/s11682-018-9971-4.

Short-afferent inhibition and cognitive impairment in Parkinson's disease: A quantitative review and challenges.

Martin-Rodriguez JF, Mir P.

Neurosci Lett. 2020 Feb 6;719:133679. doi: 10.1016/j.neulet.2018.06.048. Epub 2018 Jun 28. Review.

Pioglitazone use and Parkinson's disease: a retrospective cohort study in Taiwan.

Wu HF, Kao LT, Shih JH, Kao HH, Chou YC, Li IH, Kao S.

BMJ Open. 2018 Aug 29;8(8):e023302. doi: 10.1136/bmjopen-2018-023302.

Naturally occurring autoantibodies against α-synuclein rescues memory and motor deficits and attenuates α-synuclein pathology in mouse model of Parkinson's disease.

Huang YR, Xie XX, Ji M, Yu XL, Zhu J, Zhang LX, Liu XG, Wei C, Li G, Liu RT.

Neurobiol Dis. 2018 Nov 24. pii: S0969-9961(18)30401-7. doi: 10.1016/j.nbd.2018.11.024. [Epub ahead of print]

Basal ganglia and beyond: The interplay between motor and cognitive aspects in Parkinson's disease rehabilitation.

Ferrazzoli D, Ortelli P, Madeo G, Giladi N, Petzinger GM, Frazzitta G.

Neurosci Biobehav Rev. 2018 May 4;90:294-308. doi: 10.1016/j.neubiorev.2018.05.007. [Epub ahead of print] Review.

TREM2 overexpression attenuates neuroinflammation and protects dopaminergic neurons in experimental models of Parkinson's disease.

Ren M, Guo Y, Wei X, Yan S, Qin Y, Zhang X, Jiang F, Lou H.

Exp Neurol. 2018 Jan 27;302:205-213. doi: 10.1016/j.expneurol.2018.01.016. [Epub ahead of print]

Projections of prevalence, lifetime risk, and life expectancy of Parkinson's disease (2010-2030) in France.

Wanneveich M, Moisan F, Jacqmin-Gadda H, Elbaz A, Joly P.

Mov Disord. 2018 Aug 25. doi: 10.1002/mds.27447. [Epub ahead of print]

Multimethod assessment of everyday functioning and memory abilities in Parkinson's disease.

Fellows RP, Schmitter-Edgecombe M.

Neuropsychology. 2018 Nov 19. doi: 10.1037/neu0000505. [Epub ahead of print]

What is Functional Mobility Applied to Parkinson's Disease?

Bouça-Machado R, Maetzler W, Ferreira JJ.

J Parkinsons Dis. 2018;8(1):121-130. doi: 10.3233/JPD-171233.